Harvard Bioscience Inc (HBIO)
2.72
+0.06
(+2.26%)
USD |
NASDAQ |
Sep 27, 16:00
2.715
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience SG&A Expense (TTM): 45.99M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 45.99M |
March 31, 2024 | 46.44M |
December 31, 2023 | 46.89M |
September 30, 2023 | 47.19M |
June 30, 2023 | 47.80M |
March 31, 2023 | 48.83M |
December 31, 2022 | 49.53M |
September 30, 2022 | 51.18M |
June 30, 2022 | 50.68M |
March 31, 2022 | 50.24M |
December 31, 2021 | 48.95M |
September 30, 2021 | 46.64M |
June 30, 2021 | 44.99M |
March 31, 2021 | 42.81M |
December 31, 2020 | 43.42M |
September 30, 2020 | 43.71M |
June 30, 2020 | 45.62M |
March 31, 2020 | 46.25M |
December 31, 2019 | 46.02M |
September 30, 2019 | 47.14M |
June 30, 2019 | 45.92M |
March 31, 2019 | 46.90M |
December 31, 2018 | 45.82M |
September 30, 2018 | 42.00M |
June 30, 2018 | 39.27M |
Date | Value |
---|---|
March 31, 2018 | 35.37M |
December 31, 2017 | 32.61M |
September 30, 2017 | 34.14M |
June 30, 2017 | 35.98M |
March 31, 2017 | 38.64M |
December 31, 2016 | 41.42M |
September 30, 2016 | 41.46M |
June 30, 2016 | 41.70M |
March 31, 2016 | 41.43M |
December 31, 2015 | 40.41M |
September 30, 2015 | 39.68M |
June 30, 2015 | 37.89M |
March 31, 2015 | 36.40M |
December 31, 2014 | 35.05M |
September 30, 2014 | 34.62M |
June 30, 2014 | 35.47M |
March 31, 2014 | 36.68M |
December 31, 2013 | 37.26M |
September 30, 2013 | 36.45M |
June 30, 2013 | 36.86M |
March 31, 2013 | 36.74M |
December 31, 2012 | 37.10M |
September 30, 2012 | 37.54M |
June 30, 2012 | 36.96M |
March 31, 2012 | 35.80M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
42.81M
Minimum
Mar 2021
51.18M
Maximum
Sep 2022
47.02M
Average
46.76M
Median
SG&A Expense (TTM) Benchmarks
Bruker Corp | 805.40M |
Azenta Inc | 305.65M |
Bionano Genomics Inc | 71.68M |
Akoya Biosciences Inc | 76.87M |
Singular Genomics Systems Inc | 53.22M |